Skip to main content
. Author manuscript; available in PMC: 2020 Oct 9.
Published in final edited form as: Curr Opin Gastroenterol. 2019 Jul;35(4):302–310. doi: 10.1097/MOG.0000000000000536

Figure 2. Proactive TDM algorithm of IBD patients on biological therapy.

Figure 2.

*For relative values refer to Tables 1; **ATI >8 μg/mL-eq for ELISA and >10 U/ml for HMSA.

ADA: anti-drug antibody; IMM: immunomodulators; ATI: anti-infliximab antibodies; ELISA: enzyme-linked immunosorbent assay; HMSA: homogeneous mobility shift assay; TDM: therapeutic drug monitoring; IBD: inflammatory bowel disease.